Table 2.
The participants’ scores (mean ± s.d.) regarding application of rational pharmacotherapy process, according to the physician questionnaire.ap < 0.05, intervention vs control;b p < 0.05, baseline vs long-term
| Intervention Group (n = 12) | Control Group (n = 13) | ||||
|---|---|---|---|---|---|
| RUD rule | Max. score | Baseline | Long-term | Baseline | Long-term |
| Taking patient's history into consideration in drug choice | 8 | 4.9 ± 1.6 | 6.3 ± 1.2 | 4.9 ± 0.2.2 | 5.8 ± 2.1 |
| Comparing available drug alternatives due to efficacy, safety, suitability and cost | 4 | 1.9 ± 1.2 | 3.5 ± 1.0 | 2.6 ± 1.1 | 2.4 ± 1.2 |
| Informing the patient about the disease | 4 | 1.5 ± 0.7 | 1.8 ± 0.7 | 2.3 ± 1.0 | 1.9 ± 0.8 |
| Informing the patient about the drug(s) | 8 | 4.1 ± 1.2 | 5.2 ± 1.3 | 4.6 ± 2.5 | 4.3 ± 1.7 |
| Knowing the price of the drug(s) | 18 | 1.3 ± 1.6 | 4.0 ± 1.9 | 1.5 ± 0.6 | 0.5 ± 0.8 |